Peramivir for the treatment of influenza

Expert Review of Anti-infective Therapy
Avinash K Shetty, Leigh A Peek

Abstract

Peramivir (BioCryst Pharmaceuticals) is a novel investigational intravenous neuraminidase inhibitor that exhibits potent antiviral activity against influenza A and B viruses. Peramivir is created by a structure-based drug design and consists of a cyclopentane backbone with a positively charged guanidinyl group and lipophilic side chains. Peramivir was made available in the USA through the Emergency Investigational New Drug regulations and under an Emergency Use Authorization for hospitalized patients with known or suspected influenza during the 2009 H1N1 influenza pandemic. In trials involving ambulatory adult subjects, intravenous peramivir is safe and has a pharmacokinetic profile that supports once-daily dosing. The drug is licensed in Japan and South Korea and is currently undergoing Phase III trials in the USA. Viral resistance mechanisms to peramivir have not been fully delineated and ongoing surveillance is important. Given the serious health threat of influenza at all ages and limitations in vaccine delivery, peramivir is a promising addition to the currently limited treatment options for the treatment of severe influenza infection.

References

Jan 24, 1996·JAMA : the Journal of the American Medical Association·F G HaydenE K Hussey
Nov 18, 2000·Antiviral Research·R W Sidwell, D F Smee
Feb 15, 2001·The Journal of Infectious Diseases·L V GubarevaF G Hayden
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·D F SmeeR W Sidwell
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·R W SidwellY S Babu
Mar 21, 2001·Antimicrobial Agents and Chemotherapy·S BantiaY S Babu
Jan 10, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D YoungK Bush
Mar 19, 2002·Antimicrobial Agents and Chemotherapy·Clive SweetYarlagadda S Babu
May 31, 2002·Expert Opinion on Investigational Drugs·Robert W Sidwell, Donald F Smee
Jun 22, 2002·Antiviral Research·John D MorreyChristopher Tseng
Jul 10, 2002·Antiviral Research·Michael G IsonFrederick Hayden
Feb 28, 2003·The New England Journal of Medicine·David M WeinstockGianna Zuccotti
Aug 12, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Regina DutkowskiPenny Ward
Oct 28, 2004·Journal of Virology·Mikhail N MatrosovichHans-Dieter Klenk
May 25, 2005·Bioorganic & Medicinal Chemistry·Pooran ChandYarlagadda S Babu
Sep 30, 2005·The New England Journal of Medicine·Anne Moscona
Dec 6, 2005·Antiviral Research·Shanta BantiaPooran Chand
Jan 15, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Allison McGeerUNKNOWN Toronto Invasive Bacterial Diseases Network
Mar 11, 2008·Antiviral Research·John Beigel, Mike Bray
Dec 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frederick Hayden
Feb 11, 2009·Cell·Rachelle Salomon, Robert G Webster
Mar 5, 2009·The New England Journal of Medicine·Anne Moscona
Mar 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott A HarperUNKNOWN Expert Panel of the Infectious Diseases Society of America
Apr 10, 2009·Expert Opinion on Drug Safety·Patricia Schirmer, Mark Holodniy
Apr 28, 2009·Virology·Martha I NelsonEdward C Holmes

❮ Previous
Next ❯

Citations

Nov 1, 2013·The Journal of Microbiology·Sangmoo LeeMan-Seong Park
Mar 26, 2013·Antiviral Research·Mélanie SamsonGuy Boivin
Sep 29, 2012·Journal of Medicinal Chemistry·Beenu BhattMark von Itzstein
Nov 1, 2012·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Lidia B BrydakAneta Nitsch-Osuch
May 3, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Takashi Nakano, Kazuhito Shiosakai
Sep 26, 2015·Journal of Medicinal Chemistry·Wenming LiXin-Shan Ye
Nov 15, 2013·Influenza and Other Respiratory Viruses·Michael G Ison
Nov 15, 2013·Influenza and Other Respiratory Viruses·Guy Boivin
Jan 4, 2013·Influenza and Other Respiratory Viruses·Margaret Okomo-AdhiamboLarisa V Gubareva
Apr 12, 2013·Influenza and Other Respiratory Viruses·Margaret Okomo-AdhiamboLarisa V Gubareva
Apr 16, 2014·Influenza and Other Respiratory Viruses·Sook-Kwan LeangAeron C Hurt
Apr 12, 2016·Frontiers in Microbiology·Malak M AlameHassan Zaraket
Feb 2, 2013·Expert Opinion on Therapeutic Patents·Supakarn Chamni, Wanchai De-Eknamkul
Nov 6, 2012·Bioorganic & Medicinal Chemistry Letters·Beenu BhattMark von Itzstein
Sep 10, 2013·Antiviral Research·Andrew J BurnhamElena A Govorkova
Aug 16, 2014·The Journal of Infectious Diseases·Henju MarjukiLarisa V Gubareva
Jan 9, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Kosuke MatsuzonoShigeru Fujimoto
May 22, 2021·Biosensors & Bioelectronics·Hyeran KimJuyeon Jung
Aug 10, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hao DingJin Han
Dec 24, 2021·Influenza and Other Respiratory Viruses·Jie Wang-JairajAmanda Oliver

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.